跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IS-002
首页
药物
IS-002
IS-002
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Bacillus and application of composition thereof
申请人: UNIV QINGDAO AGRICULTURAL
优先权: 2025
CN
Rhodotorula glutinis LUCNOVA 002 as well as fermentation inoculant and application thereof
申请人: LUCNOVA BIO TECH CO LTD HUBEI
优先权: 2025
CN
Composite microbial agent and application thereof
申请人: INST MICROBIOLOGY CAS
优先权: 2023
CN
Cat-derived lactobacillus reuteri, metagen, pharmaceutical composition and application of cat-derived lactobacillus reuteri, metagen and pharmaceutical composition
申请人: HANGZHOU GAOYE JIAYOUHAO DUOMAO PET FOOD CO LTD
优先权: 2024
CN
Preparation method of tetrahydropyrrole compound
申请人: MAIDIKANG SHANGHAI BIO MEDICINE TECH CO LTD
优先权: 2019
CN
Preparation method of tetrahydropyrrole compound
申请人: MAIDIKANG SHANGHAI BIO MEDICINE TECH CO LTD
优先权: 2019
CN
Preparation method of latamoxef mother nucleus
申请人: SHANXI QIANXIU PHARMACEUTICALS CO LTD
优先权: 2019
CN
Hair-consolidating, hair-loss-preventing and hair-blackening composite-effect liposome and preparation method thereof
申请人: XINZHIJIE SUZHOU BIOTECHNOLOGY CO LTD
优先权: 2024
CN
药物
反馈